Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $391,448 | 114 | 65.8% |
| Consulting Fee | $98,755 | 41 | 16.6% |
| Travel and Lodging | $94,554 | 159 | 15.9% |
| Food and Beverage | $7,496 | 168 | 1.3% |
| Honoraria | $2,500 | 1 | 0.4% |
| Education | $20.67 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $530,006 | 373 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $34,867 | 60 | $0 (2020) |
| Eisai Co., Ltd. | $13,750 | 3 | $0 (2020) |
| Millennium Pharmaceuticals, Inc. | $7,420 | 6 | $0 (2017) |
| Incyte Corporation | $4,837 | 7 | $0 (2017) |
| ARRAY BIOPHARMA INC | $2,617 | 12 | $0 (2021) |
| Celgene Corporation | $662.57 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $197.69 | 6 | $0 (2019) |
| Genentech USA, Inc. | $107.02 | 6 | $0 (2018) |
| Amgen Inc. | $103.92 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,100 | 6 | E.R. Squibb & Sons, L.L.C. ($1,500) |
| 2021 | $4,462 | 3 | ARRAY BIOPHARMA INC ($2,500) |
| 2020 | $118,075 | 63 | E.R. Squibb & Sons, L.L.C. ($100,308) |
| 2019 | $145,209 | 113 | E.R. Squibb & Sons, L.L.C. ($128,409) |
| 2018 | $142,495 | 131 | E.R. Squibb & Sons, L.L.C. ($131,245) |
| 2017 | $182,432 | 170 | E.R. Squibb & Sons, L.L.C. ($166,594) |
All Payment Transactions
486 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/15/2022 | Celgene Corporation | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 06/15/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 06/15/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 04/13/2022 | Celgene Corporation | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 04/13/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 03/21/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 02/19/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: Oncology | ||||||
| 01/07/2021 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug) | Honoraria | Cash or cash equivalent | $2,500.00 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Oncology | ||||||
| 12/14/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Oncology | ||||||
| 12/08/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Oncology | ||||||
| 12/08/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $630.00 | General |
| Category: Oncology | ||||||
| 12/03/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: ONCOLOGY | ||||||
| 12/01/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Oncology | ||||||
| 12/01/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Oncology | ||||||
| 11/12/2020 | Eisai Co., Ltd. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Oncology | ||||||
| 10/29/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Oncology | ||||||
| 10/27/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,070.00 | General |
| Category: Oncology | ||||||
| 10/27/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Oncology | ||||||
| 10/23/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: Oncology | ||||||
| 10/20/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Oncology | ||||||
| 10/13/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Oncology | ||||||
| 10/06/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,520.00 | General |
| Category: Oncology | ||||||
| 10/02/2020 | Eisai Co., Ltd. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $6,250.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 3 | 204 | 392 | $179,872 | $29,763 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 118 | 273 | $105,378 | $17,307 | 16.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 52 | 85 | $46,410 | $7,622 | 16.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 34 | 34 | $28,084 | $4,835 | 17.2% |
About Dr. Steven O'day, M.D
Dr. Steven O'day, M.D is a Hematology & Oncology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518070812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven O'day, M.D has received a total of $594,773 in payments from pharmaceutical and medical device companies, with $2,100 received in 2022. These payments were reported across 486 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($391,448).
As a Medicare-enrolled provider, O'day has provided services to 204 Medicare beneficiaries, totaling 392 services with total Medicare billing of $29,763. Data is available for 1 year (2020–2020), covering 3 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Santa Monica, CA
- Active Since 08/17/2006
- Last Updated 03/07/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1518070812
Products in Payments
- OPDIVO (Biological) $399,857
- Lenvima (Drug) $13,750
- ENTYVIO (Biological) $7,420
- KEYTRUDA (Biological) $3,637
- BRAFTOVI (Drug) $2,500
- LENVIMA (Drug) $1,813
- MK-7339 (Drug) $152.97
- MEKINIST (Drug) $143.70
- Braftovi (Drug) $116.58
- PHASIX (Device) $94.51
- Nplate (Biological) $67.66
- TECENTRIQ (Biological) $46.08
- KISQALI (Drug) $45.57
- IMLYGIC (Biological) $36.26
- Xtandi (Drug) $31.22
- ZOLADEX (Drug) $26.42
- LIBTAYO (Biological) $24.11
- Avastin (Biological) $21.91
- Alecensa (Biological) $20.16
- Herceptin (Biological) $18.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Santa Monica
Omid Hamid, M.d, M.D
Hematology & Oncology — Payments: $981,950
Steven Wong, Md, MD
Hematology & Oncology — Payments: $421,118
Silvana Martino, D.o, D.O
Hematology & Oncology — Payments: $179,144
Miss. Blanca Ledezma, Msn, Np, MSN, NP
Hematology & Oncology — Payments: $148,836
Dr. Arun Singh, M.d, M.D
Hematology & Oncology — Payments: $121,941
Dr. William Isacoff, M.d, M.D
Hematology & Oncology — Payments: $108,579